Hence, pyroptosis-mediated antitumor role is specific of exon6-expressing isoforms, but further studies are required to confirm if GSDMB pro-tumor functions, like cell motility [35, 42, 48] and resistance to anti-HER2 therapies [40], are common to all four isoforms. This evidence concerns the gene ERBB2 and neoplasm.